Literature DB >> 25758938

Prognostic value of surgical margins during endoscopic resection of paranasal sinus malignancy.

Lakshman Manjunath1, Taylor Derousseau1, Pete S Batra2.   

Abstract

BACKGROUND: Complete tumor resection with intraoperative frozen section control remains a central tenet of head and neck surgical oncology. The purpose of this study was to evaluate the significance of margins in predicting recurrence and disease status following endoscopic resection of sinonasal malignancy.
METHODS: This single-institution observational cohort study was performed on 68 patients over a 5-year period who underwent curative minimally invasive endoscopic resection (MIER) for sinonasal malignancies.
RESULTS: The mean age was 58.8 years and 69.1% were male. The mean follow-up after definitive MIER was 15.9 months. A mean of 10.8 margins were taken per surgery (range, 2 to 27). False-negative frozen section analysis was 22.1% for the entire cohort, but slightly higher at 25.0% for T3 or T4 malignancies. At last follow-up, no evidence of disease (NED) status was noted in 60.0% of those with positive margins vs 83.0% in those with negative margins, respectively (p = 0.0795). Regional or distant recurrences were observed in 39.9% of patients with positive margins and 13.2% of those with negative margins, respectively (p = 0.0299). Disease-free survival (DFS) was 9.7 months for patients with positive margins, whereas it was 15.9 months for patients with negative margins.
CONCLUSION: Disease-free status as a function of residual microscopic disease did not prove to be statistically significant. However, positive margins were correlated with a statistically significant increase in regional or distant recurrence. This suggests that complete resection with clear margins can impact oncologic outcomes in patients managed by MIER for sinonasal cancers.
© 2015 ARS-AAOA, LLC.

Entities:  

Keywords:  cancer; endoscopy; malignancy; neoplasm; paranasal; sinus; skull base; surgical margin

Mesh:

Year:  2015        PMID: 25758938     DOI: 10.1002/alr.21463

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  4 in total

1.  Multi-modality Treatment and Survival in Sinonasal Minor Salivary Gland Tumors.

Authors:  Sina J Torabi; Todd Spock; Bruno Cardoso; Janet Chao; R Peter Manes; Benjamin L Judson
Journal:  J Neurol Surg B Skull Base       Date:  2019-04-01

Review 2.  Endonasal Endoscopic Surgery in the Management of Sinonasal and Anterior Skull Base Malignancies.

Authors:  Christopher R Roxbury; Masaru Ishii; Jeremy D Richmon; Ari M Blitz; Douglas D Reh; Gary L Gallia
Journal:  Head Neck Pathol       Date:  2016-02-01

3.  Endoscopic Fluorescence-Guided Surgery for Sinonasal Cancer Using an Antibody-Dye Conjugate.

Authors:  Zachary P Hart; Naoki Nishio; Giri Krishnan; Guolan Lu; Quan Zhou; Shayan Fakurnejad; Peter John Wormald; Nynke S van den Berg; Eben L Rosenthal; Fred M Baik
Journal:  Laryngoscope       Date:  2019-12-19       Impact factor: 3.325

4.  Surgical Treatment of Sinonasal Mucosal Melanoma in Patients Treated with Systemic Immunotherapy.

Authors:  Tiffany N Chao; Edward C Kuan; Charles C L Tong; Michael A Kohanski; M Sean Grady; James N Palmer; Nithin D Adappa; Bert W O'Malley
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.